Omeros (OMER) News Today $11.11 -0.84 (-7.03%) (As of 12:51 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Lightning Round: Take a pass on AstraZeneca, says Jim CramerDecember 2 at 10:48 PM | msn.comOmeros Corp (OMER) Stock Surges Amid Biotech Sector ActivityDecember 2 at 4:06 PM | gurufocus.comOmeros Corporation Announces Upcoming Presentations at ASH Annual MeetingDecember 2 at 9:25 AM | gurufocus.comOmeros Corporation Announces Upcoming Presentations at ASH Annual MeetingDecember 2 at 8:45 AM | businesswire.comOmeros (NASDAQ:OMER) Shares Gap Down - Should You Sell?November 29, 2024 | americanbankingnews.comOmeros Corp (OMER) Stock Surges Amidst Biotech Sector ActivityNovember 26, 2024 | gurufocus.comOmeros nears resubmission of narsoplimab BLANovember 23, 2024 | uk.investing.comOmeros Updates Progress on Narsoplimab Biologics License Resubmission; Stock up Over 30% on NewsNovember 22, 2024 | gurufocus.comOmeros (NASDAQ:OMER) Hits New 1-Year High - Here's What HappenedOmeros (NASDAQ:OMER) Hits New 12-Month High - Still a Buy?November 22, 2024 | marketbeat.comOmeros provides update on narsoplimab BLA resubmissionNovember 22, 2024 | markets.businessinsider.comOmeros Corporation Provides Update on Progress Toward BLA ResubmissionNovember 21, 2024 | businesswire.comOmeros (NASDAQ:OMER) Upgraded at StockNews.comStockNews.com upgraded shares of Omeros from a "sell" rating to a "hold" rating in a research note on Wednesday.November 20, 2024 | marketbeat.comOmeros Q3 2024 - Updates On OMIDRIA And Narsoplimab Lead To Liquidity ConcernsNovember 17, 2024 | seekingalpha.comRodman & Renshaw Initiates Coverage of Omeros (OMER) with Buy RecommendationNovember 15, 2024 | msn.comOmeros (NASDAQ:OMER) Raised to "Strong-Buy" at RODMAN&RENSHAWRODMAN&RENSHAW raised Omeros to a "strong-buy" rating in a research note on Thursday.November 15, 2024 | marketbeat.comQ3 2024 Omeros Corp Earnings CallNovember 15, 2024 | finance.yahoo.comOmeros (OMER) Gets a Hold from NeedhamNovember 15, 2024 | markets.businessinsider.comOmeros initiated with a Buy at Rodman & RenshawNovember 15, 2024 | markets.businessinsider.comOmeros Shares Hit 52-Week High on Plan to Resubmit Narsoplimab ApplicationNovember 15, 2024 | marketwatch.comOmeros Skyrockets on $200M Milestone PaymentNovember 14, 2024 | msn.comOmeros' (OMER) "Neutral" Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reiterated a "neutral" rating on shares of Omeros in a research report on Thursday.November 14, 2024 | marketbeat.comOmeros (NASDAQ:OMER) Given Hold Rating at Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Omeros in a research report on Thursday.November 14, 2024 | marketbeat.comOmeros (NASDAQ:OMER) Coverage Initiated at Rodman & RenshawRodman & Renshaw assumed coverage on Omeros in a research note on Thursday. They issued a "buy" rating and a $9.00 price objective for the company.November 14, 2024 | marketbeat.comOmeros Corp (OMER) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial AdjustmentsNovember 14, 2024 | gurufocus.comOmeros Corporation (OMER) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comOmeros Corporation Reports Third Quarter 2024 Financial ResultsNovember 13, 2024 | businesswire.comEarnings Outlook For OmerosNovember 12, 2024 | benzinga.comOmeros (OMER) Scheduled to Post Earnings on WednesdayOmeros (NASDAQ:OMER) will be releasing earnings after the market closes on Wednesday, November 13, Zacks reports.November 12, 2024 | marketbeat.comOmeros Corporation to Announce Third Quarter Financial Results on November 13, 2024November 11, 2024 | businesswire.comOmeros (NASDAQ:OMER) Stock Passes Above Two Hundred Day Moving Average - Here's WhyOmeros (NASDAQ:OMER) Shares Cross Above 200-Day Moving Average - Here's What HappenedNovember 6, 2024 | marketbeat.comOmeros (NASDAQ:OMER) Stock Quotes, Forecast and News SummaryNovember 1, 2024 | benzinga.comOmeros receives rare pediatric disease designation for zaltenibart from FDAOctober 25, 2024 | markets.businessinsider.comOmeros' Zaltenibart Gets Rare Pediatric Disease Designation From FDA For C3 GlomerulopathyOctober 24, 2024 | markets.businessinsider.comAllogeneic Hematopoietic Stem Cell Transplant Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsightOctober 22, 2024 | finance.yahoo.com3D printing on the move: UW device can map a room and print custom items in desired spaceOctober 22, 2024 | msn.comKorean Novelist Han Kang Wins Nobel Prize in Literature, 1st for South KoreaOctober 10, 2024 | msn.comOmeros (NASDAQ:OMER) Share Price Crosses Above 200 Day Moving Average - Time to Sell?Omeros (NASDAQ:OMER) Shares Cross Above Two Hundred Day Moving Average - Should You Sell?October 5, 2024 | marketbeat.comGlobal Nicotine Replacement Therapy Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2030 | DelveInsightSeptember 27, 2024 | finance.yahoo.comTech Moves: GE healthcare exec joins startup; Nautilus taps new CMO; WRF investor steps downSeptember 27, 2024 | msn.comRetail investors account for 52% of Omeros Corporation's (NASDAQ:OMER) ownership, while institutions account for 43%September 3, 2024 | uk.finance.yahoo.comOMER Nov 2024 9.000 callAugust 17, 2024 | ca.finance.yahoo.comOMER Sep 2024 6.000 putAugust 17, 2024 | ca.finance.yahoo.comResearch Analysts Set Expectations for Omeros Co.'s FY2024 Earnings (NASDAQ:OMER)Omeros Co. (NASDAQ:OMER - Free Report) - Equities research analysts at Cantor Fitzgerald lifted their FY2024 earnings per share estimates for shares of Omeros in a report issued on Monday, August 12th. Cantor Fitzgerald analyst O. Brayer now forecasts that the biopharmaceutical company will postAugust 14, 2024 | marketbeat.comOptimistic Buy Rating on Clearside Biomedical Amid Promising CLS-AX Trial OutcomesAugust 13, 2024 | markets.businessinsider.comOmeros Corp (3O8.MU)August 11, 2024 | nz.finance.yahoo.comOmeros Corporation (OMER) Q2 2024 Earnings Call TranscriptAugust 11, 2024 | seekingalpha.comOMER Stock Earnings: Omeros Misses EPS for Q2 2024August 7, 2024 | investorplace.comOmeros Corporation Reports Second Quarter 2024 Financial ResultsAugust 7, 2024 | finance.yahoo.comOmeros (OMER) Scheduled to Post Quarterly Earnings on WednesdayOmeros (NASDAQ:OMER) will be releasing earnings after the market closes on Wednesday, August 7, Zacks reports.August 6, 2024 | marketbeat.comOmeros Co. to Post FY2024 Earnings of ($2.93) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:OMER)Omeros Co. (NASDAQ:OMER - Free Report) - Cantor Fitzgerald cut their FY2024 earnings per share (EPS) estimates for Omeros in a research note issued to investors on Thursday, August 1st. Cantor Fitzgerald analyst O. Brayer now expects that the biopharmaceutical company will earn ($2.93) per shareAugust 5, 2024 | marketbeat.com Get Omeros News Delivered to You Automatically Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter. Email Address Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soon Click here to watch it now. OMER Media Mentions By Week OMER Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OMER News Sentiment▼0.440.87▲Average Medical News Sentiment OMER News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OMER Articles This Week▼72▲OMER Articles Average Week Get Omeros News Delivered to You Automatically Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SUPN News PCRX News NKTR News ASMB News CPIX News LLY News JNJ News ABBV News MRK News PFE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OMER) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omeros Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omeros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
